PharmaVoice Recognizes Syneos Health’s Jane Williams as a 100 Most Inspiring Leader in Life Sciences Industry
Williams Known for Unwavering Dedication to Advancing Medical Innovation and Commitment to Health Equity
October 17, 2024
MORRISVILLE, N.C., October 17, 2024 - Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today announced Jane Williams, MD, MPH, FAAFP, Vice President, Head of Neuroscience, Rare Disease and Pediatrics, has been honored as a PharmaVoice 100 winner. This annual list recognizes the most inspiring people in the life sciences industry.
Jane is a dynamic leader, widely known for her transformative impact and commitment to excellence. With decades of experience in clinical, academic, and healthcare management, she advocates passionately for health equity, drives diverse representation in clinical trials and champions underserved populations. Acting as an executive advisor to the Company’s Asian Employee Resource Group, her drive for gender equity and professional development fosters a more inclusive healthcare environment.
"We are immensely proud of Jane for being recognized as one of PharmaVoice's 100 most inspiring leaders. This honor reflects her unwavering commitment to excellence and equity – within and outside our organization,” said Michael Brooks, Chief Operating Officer, Syneos Health. “Jane's leadership inspires our teams worldwide to strive for breakthroughs in drug development that advance a healthier future for all."
PharmaVoice 100 honorees are selected from a pool of nominations submitted by readers and colleagues, evaluated by the PharmaVoice team, then categorized into 10 distinct groups: Standout Leaders, Cancer Care Visionaries, Cardiometabolic All-Stars, Trailblazers, Biotech Pathfinders, Rare Disease Warriors, Tech and AI Wizards, Clinical Trial Pros, Patient Champions and Cell and Gene Therapy Pioneers. Williams was recognized in the Patient Champions category.
“These honorees are inspirations. Their teams look to them for guidance, their patients for support and their organizations for direction,” said Meagan Parrish, lead editor of PharmaVoice. “Each winner represents progress toward a healthier future for everyone that is bolstered by science and technological advancements. We are excited to recognize their contributions through this annual list.”
Since 2005, the PharmaVoice 100 has become one of the publication’s most anticipated features. From academia and nonprofits to Big Pharma, startups and tech companies, it is the only industry awards program that honors individuals from all sectors of life sciences. These honorees, from the clinic to the C-suite, are making meaningful contributions to their fields and striving to improve outcomes for patients around the world.
About Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com.
About PharmaVoice
PharmaVoice is a leading industry publication operated by Industry Dive. Our stories deliver the most important voices and ideas in the life sciences to industry leaders.
About Industry Dive
Industry Dive, an Informa business, is a leading business journalism company. Over 14 million decision-makers across 20+ competitive industries rely on our exclusive insight and analysis delivered through more than 30 publications.
Press/Media Contact:
Meg Byers
Director, External Communications
+1 607 215 1330
